NCT01577732
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Haiphong, Vietnam
Clinical trial condition
Actinomycetales Infections
Explore clinical trials studying Actinomycetales Infections. Study availability and eligibility vary by location and protocol.
1,556 public trials
161 recruiting studies
Actinomycetales Infections trial results
NCT02853929
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
- Locations
-
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Halifax, Nova Scotia, Canada
- GSK Investigational Site Montreal, Quebec, Canada
NCT00548171
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia
NCT03950986
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
- Locations
-
- Atlanta VA Medical Center Decatur, Georgia, United States
NCT00352963
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
- Locations
-
- GSK Investigational Site Alcorcón, Spain
- GSK Investigational Site Almeira, Spain
- GSK Investigational Site Badalona, Spain
- GSK Investigational Site Barcelona, Spain
Completed
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
NCT00835237
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site DeLand, Florida, United States
- GSK Investigational Site West Palm Beach, Florida, United States
NCT00970307
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland
Completed
Post Market Surveillance for Infanrix™
NCT00908115
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Daegu, South Korea
NCT00463437
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
- Locations
-
- GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
- GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
NCT01353703
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Belgaun, India
- GSK Investigational Site Chennai, India
- GSK Investigational Site Pune, India
- GSK Investigational Site Pune, India